Parenteral Nutrition Market Size To Reach $10.68 Billion By 2030

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 10.68 billion by 2030, registering a CAGR of 6.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.

The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.

Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.

 Request a free sample copy or view report summary: Parenteral Nutrition Market Report

Parenteral Nutrition Market Report Highlights

• Based on nutrient type, the market is segmented into carbohydrates, parenteral lipid emulsions, single-dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid segment held the largest revenue share of 30.7% in 2023 owing to its compatibility with all age groups and its lesser adverse effects compared to other types of parenteral nutrition

• Based on stage, the adult segment dominated the market with a revenue share of 87.1% in 2023 owing to the vulnerability of the elderly population to various chronic conditions such as cancer, diabetes, and Alzheimer's disease

• Institutional sales channel dominated the market with the largest revenue share of 48.1% in 2023. On the other hand, online channels are anticipated to exhibit the fastest growth rate over the forecast period

• In 2023, North America held the largest revenue share of 41.5%, while Asia Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving healthcare infrastructure, growing per capita income, and high occurrence of preterm births

Parenteral Nutrition Market Segmentation

Grand View Research has segmented the global parenteral nutrition market based on nutrient type, stage type, indication, sales channel, and region:

Parenteral Nutrition Nutrient Type Outlook (Revenue, USD Million, 2018 - 2030)

• Carbohydrates

• Parenteral Lipid Emulsion

• Single Dose Amino Acid Solution

• Trace Elements

• Vitamins & Minerals

Parenteral Nutrition Stage Type Outlook (Revenue, USD Million, 2018 - 2030)

• Adult

• Pediatrics

Parenteral Nutrition Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Alzheimer’s

• Nutrition Deficiency

• Cancer Care

• Diabetes

• Chronic Kidney Diseases

• Orphan Diseases

• Dysphagia

• Pain Management

• Malabsorption/GI Disorder/Diarrhea

• Others

Parenteral Nutrition Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Online

• Retail

• Institutional

Parenteral Nutrition Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • Germany

  • UK

  • Italy

  • Spain

  • France

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • China

  • India

  • Japan

  • Thailand

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Parenteral Nutrition Market

• Baxter

• Allergan

• Actavis Inc.

• Otsuka Pharmaceutical Factory, Inc.

• Grifols, S.A.

• B. Braun Melsungen AG

• Vifor Pharma

• Fresenius Kabi AG

• Sichuan Kelun Pharmaceutical Co., Ltd.

• Pfizer Inc. (Hospira Inc.)